Vanda Pharmaceuticals, Inc. (VNDA)
3.76
+0.17
(+4.74%)
USD |
NASDAQ |
Nov 06, 10:28
Vanda Pharmaceuticals Market Cap : 227.36M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 217.08M |
| November 04, 2026 | 234.62M |
| November 03, 2026 | 226.76M |
| November 02, 2026 | 234.62M |
| October 30, 2026 | 229.18M |
| October 29, 2026 | 244.90M |
| October 28, 2026 | 241.88M |
| October 27, 2026 | 241.27M |
| October 26, 2026 | 238.19M |
| October 23, 2026 | 242.42M |
| October 22, 2026 | 244.84M |
| October 21, 2026 | 242.42M |
| October 20, 2026 | 252.10M |
| October 19, 2026 | 247.26M |
| October 16, 2026 | 243.63M |
| October 15, 2026 | 256.33M |
| October 14, 2026 | 255.12M |
| October 13, 2026 | 259.96M |
| October 12, 2026 | 274.46M |
| October 09, 2026 | 276.28M |
| October 08, 2026 | 273.86M |
| October 07, 2026 | 275.67M |
| October 06, 2026 | 273.26M |
| October 05, 2026 | 276.88M |
| October 02, 2026 | 279.91M |
| Date | Value |
|---|---|
| October 01, 2026 | 290.79M |
| September 30, 2026 | 296.83M |
| September 29, 2026 | 304.09M |
| September 28, 2026 | 312.55M |
| September 25, 2026 | 305.30M |
| September 24, 2026 | 301.06M |
| September 23, 2026 | 304.69M |
| September 22, 2026 | 314.97M |
| September 21, 2026 | 311.64M |
| September 18, 2026 | 310.13M |
| September 17, 2026 | 308.92M |
| September 16, 2026 | 302.27M |
| September 15, 2026 | 301.67M |
| September 14, 2026 | 311.34M |
| September 11, 2026 | 307.71M |
| September 10, 2026 | 304.69M |
| September 09, 2026 | 317.39M |
| September 08, 2026 | 322.22M |
| September 04, 2026 | 328.27M |
| September 03, 2026 | 322.83M |
| September 02, 2026 | 334.31M |
| September 01, 2026 | 327.66M |
| August 31, 2026 | 326.46M |
| August 28, 2026 | 319.81M |
| August 27, 2026 | 328.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 1.591B |
| Protagonist Therapeutics, Inc. | 8.407B |
| Sagimet Biosciences, Inc. | 581.99M |
| ACADIA Pharmaceuticals, Inc. | 3.594B |
| Alnylam Pharmaceuticals, Inc. | 21.19B |
Market Cap Related Metrics
| PS Ratio | 0.9808 |
| PEG Ratio | -0.0037 |
| Price to Book Value | 1.138 |
| Price | 3.76 |
| Earnings Yield | -122.8% |
| PEGY Ratio | -0.0037 |